News
NAGE
2.440
+0.41%
0.010
Niagen Bioscience launches Niagen At-Home Injection Kit
TipRanks · 4d ago
Niagen Bioscience Launches Niagen™ Plus Liquid At-Home Injections to Support Telehealth Expansion
Barchart · 4d ago
Niagen Bioscience announces debut of Tru Niagen Skincare
TipRanks · 6d ago
Niagen Bioscience Makes Skincare a Permanent Tru Niagen® Category, Launching Dermatologist-Tested Niagen NanoCloud™ as a Core Tru Niagen® Product
Barchart · 6d ago
Weekly Report: what happened at NAGE last week (1012-1016)?
Weekly Report · 10/19 09:18
Analysts Are Bullish on Top Consumer Goods Stocks: Niagen Bioscience (NAGE), Ollie’s Bargain Outlet Holding (OLLI)
TipRanks · 10/12 12:10
Weekly Report: what happened at NAGE last week (1005-1009)?
Weekly Report · 10/12 09:19
Andrew Shao, Ph.D., Senior Vice President of Global Regulatory and Scientific Affairs at Niagen Bioscience, Honored with the 2026 Annette Dickinson Trailblazer Award by Radicle Science and Council for Responsible Nutrition (CRN)
Barchart · 10/08 07:32
Analysts Offer Insights on Consumer Goods Companies: Niagen Bioscience (NAGE) and Target (TGT)
TipRanks · 10/05 11:10
Weekly Report: what happened at NAGE last week (0928-1002)?
Weekly Report · 10/05 09:19
Niagen Bioscience launches ‘Don’t Get Old. Age Better.’ campaign
TipRanks · 10/01 12:50
Niagen Bioscience Puts 25 Years of NAD+ Science Behind "Don't Get Old. Age Better.®” a New Campaign for its Niagen® Brand Featuring Legendary Surfer Kelly Slater
Barchart · 10/01 07:32
Niagen Bioscience enters start-up agreement with Mass General Brigham
TipRanks · 09/30 12:40
Niagen Bioscience Enters Start-Up Agreement With Mass General Brigham To Plan The Largest And Most Comprehensive Clinical Trial Of Niagen To Date
Benzinga · 09/30 12:39
Transcript: Niagen Bioscience Q2 2026 Earnings Conference Call
Benzinga · 09/30 10:55
Niagen Bioscience: Down 68%, But Still Not Quite A Buy
Seeking Alpha · 09/29 14:05
Weekly Report: what happened at NAGE last week (0921-0925)?
Weekly Report · 09/28 09:18
Analysts Offer Insights on Consumer Goods Companies: Niagen Bioscience (NAGE) and Keurig Dr Pepper (KDP)
TipRanks · 09/25 11:10
Niagen Bioscience announces publication of preclinical study on CD38
TipRanks · 09/21 12:40
Niagen Bioscience Highlights Preclinical Research Linking CD38-Driven NAD+ Depletion To Placental Aging; NOTE: Niagen Bioscience Did Not Conduct, Fund, Or Design This Study, And The NR Used Was Not The Company’s Niagen Ingredient
Benzinga · 09/21 12:35
More
Webull provides a variety of real-time NAGE stock news. You can receive the latest news about Niagen Bioscience, Inc through multiple platforms. This information may help you make smarter investment decisions.
About NAGE
Niagen Bioscience, Inc. is a global bioscience company promoting healthy aging. Its segments include Consumer Products, Ingredients segment, Analytical Reference Standards and Services and Pharmaceuticals. The Consumer Products segment provides finished dietary supplement products that contain its proprietary ingredient, Niagen, directly to consumers and distributors. The ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and outsourcing facilities. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services. The Pharmaceutical segment comprises pharmaceutical development of its proprietary molecules for potential therapeutic applications in rare diseases and conducts research and development activities.